Abstract:Background: The management of gastric cancer (GC) still lacks tumor markers with high specificity and sensitivity. The goal of current research is to find effective diagnostic and prognostic markers and to clarify their related mechanisms. Methods: In this study, we integrated GC DNA methylation data from publicly available datasets obtained from TCGA and GEO databases, and applied random forest and LASSO analysis methods to screen reliable differential methylation sites (DMSs) for GC diagnosis. We constructed a diagnostic model of GC by logistic analysis and conducted verification and clinical correlation analysis. We screened credible prognostic DMSs through univariate Cox and LASSO analyses and verified a prognostic model of GC by multivariate Cox analysis. Independent prognostic and biological function analyses were performed for the prognostic risk score. We performed TP53 correlation analysis, mutation and prognosis analysis on eleven-DNA methylation driver gene (DMG), and constructed a multifactor regulatory network of key genes. Results: The five-DMS diagnostic model distinguished GC from normal samples, and diagnostic risk value was significantly correlated with grade and tumor location. The prediction accuracy of the eleven-DMS prognostic model was verified in both the training and validation datasets, indicating its certain potential for GC survival prediction. The survival rate of the high-risk group was significantly lower than that of the low-risk group. The prognostic risk score was an independent risk factor for the prognosis of GC, which was significantly correlated with N stage and tumor location, positively correlated with the VIM gene, and negatively correlated with the CDH1 gene. The expression of CHRNB2 decreased significantly in the TP53 mutation group of gastric cancer patients, and there were significant differences in CCDC69, RASSF2, CHRNB2, ARMC9, and RPN1 between the TP53 mutation group and the TP53 non-mutation group of gastric cancer patients. In addition, CEP290, UBXN8, KDM4A, RPN1 had high frequency mutations and the function of eleven-DMG mutation related genes in GC patients is widely enriched in multiple pathways. Conclusion: Combined, the five-DMS diagnostic and eleven-DMS prognostic GC models are important tools for accurate and individualized treatment. The study provides direction for exploring potential markers of GC.

Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china.

CpG Island Methylator Phenotype and Its Association with Malignancy in Sporadic Duodenal Adenomas

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma

Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions

Germline promoter hypermethylation of tumor suppressor genes in gastric cancer

High Cpg Island Methylator Phenotype is Associated with Lymph Node Metastasis and Prognosis in Gastric Cancer

Genome-wide DNA methylation profiling reveals a novel hypermethylated biomarker PRKCB in gastric cancer

A Study on CpG Island Methylator Phenotype involving Tumor Suppressor Genes on Chromosome 3p in Gastric Cancer

Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.

Association between p16 methylation and malignant transformation of gastric dysplasia

Distinct methylation pattern and microsatellite instability in sporadic gastric cancer

DNA methylation profiling identifies epigenetic signatures of early gastric cancer

Hypermethylation of Multiple Tumor-Related Genes in Gastric Carcinoma and Adjacent Normal Tissues

Dna Methylation Markers As Predictors Of Initiation And Progression Of Gastric Carcinomas

Recognition of DNA Methylation Molecular Features for Diagnosis and Prognosis in Gastric Cancer

Methylation of P16 CpG Islands Correlated with Malignant Progression of Gastric Dysplasia in a Nested Case-Control Study

Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population

Methylation Of P16 Cpg Islands Associated With Malignant Transformation Of Gastric Dysplasia In A Population-Based Study

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Unique Characteristics of CpG Island Methylator Phenotype (CIMP) in a Chinese Population with Colorectal Cancer